<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04006249</url>
  </required_header>
  <id_info>
    <org_study_id>2009-A00998-49</org_study_id>
    <nct_id>NCT04006249</nct_id>
  </id_info>
  <brief_title>Haemochromatosis and Periodontitis</brief_title>
  <acronym>HEMOPARO</acronym>
  <official_title>Haemochromatosis and Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Periodontitis is a chronic inflammatory disease that affects tissues surrounding the teeth.&#xD;
      It is strongly associated with the major pathogenic &quot;red complex&quot;, including Porphyromonas&#xD;
      gingivalis, Tannerella forsythia and Treponema denticola1 and thus is considered an&#xD;
      infection. Recent advances in the pathogenesis of periodontal disease have suggested that&#xD;
      polymicrobial synergy and microbiota dysbiosis together with a dysregulated immune response&#xD;
      can induce inflammation-mediated damage in periodontal tissues2-4. Interestingly, currently&#xD;
      periodontitis is associated with a growing number of systemic diseases, including&#xD;
      cardiovascular diseases, adverse pregnancy outcomes, diabetes5-7 and hereditary&#xD;
      haemochromatosis8.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 6, 2010</start_date>
  <completion_date type="Actual">December 1, 2011</completion_date>
  <primary_completion_date type="Actual">September 22, 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of periodontal diseases</measure>
    <time_frame>2 years</time_frame>
    <description>To evaluate the prevalence of periodontal diseases in patients with hemochromatosis at the time of diagnosis and / or their usual therapeutic</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>to Evaluate the Prevalence of Periodontal Diseases in Patients With Hemochromatosis at the Time of Diagnosis and / or Their Usual Therapeutic</condition>
  <arm_group>
    <arm_group_label>diagnostic test</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>dental probes</intervention_name>
    <description>Measurement of the depth of the periodontal pockets and clinical loss</description>
    <arm_group_label>diagnostic test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 35 to 64 years with homozygosity hemochromatosis C282Y&#xD;
&#xD;
          -  Patients regularly enrolled in a health insurance plan&#xD;
&#xD;
          -  Patients with at least 10 natural teeth&#xD;
&#xD;
          -  Patients who have given informed written, dated and signed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetic patients&#xD;
&#xD;
          -  Simultaneous participation in another study&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  The incapacitated persons and persons deprived of their liberty&#xD;
&#xD;
          -  Patients who do not speak French, both written and spoken&#xD;
&#xD;
          -  Patients previously included in this trial&#xD;
&#xD;
          -  Patients with heart valves or endovascular equipment (risk of infective endocarditis&#xD;
             ...)&#xD;
&#xD;
          -  Patients with a history of maxillofacial surgery&#xD;
&#xD;
          -  Patients whose oral status is considered incompatible with entry into the study, at&#xD;
             the discretion of the investigator&#xD;
&#xD;
          -  Patients on drugs that can cause gingival hypertrophy, such as Hydantoins (phenytoin),&#xD;
             Dihydropyridines, Diltiazem or Ciclosporin&#xD;
&#xD;
          -  Patients on medication that can cause gingival bleeding (anticoagulants, antiplatelet&#xD;
             agents and aspirin).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 1, 2019</last_update_submitted>
  <last_update_submitted_qc>July 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Hemochromatosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

